Cerity Partners
FBLG icon

Cerity Partners’s FibroBiologics FBLG Stock Holding History

Cerity Partners’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,696
Closed -$21.1K – 3405
2025
Q4 		$21.1K Sell
4,696
-1,600
-25% -$11.3K ﹤0.01% 2847
2025
Q3 		$68.8K Sell
6,296
-109
-2% -$1.3K ﹤0.01% 2665
2025
Q2 		$79.7K Buy
6,405
+1,735
+37% +$31.3K ﹤0.01% 2510
2025
Q1 		$84.1K Buy
4,670
+765
+20% +$21.9K ﹤0.01% 2343
2024
Q4 		$156K Buy
3,905
+1,300
+50% +$69.8K ﹤0.01% 2280
2024
Q3 		$161K Buy
+2,605
New +$173K ﹤0.01% 2365

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $215B AUM

Cerity Partners's FBLG Position: Q1 2026 in Review

Cerity Partners sold out of FibroBiologics (FBLG) in Q1 2026, closing a stake of 4,696 shares — an estimated $21.1K sold.

Cerity Partners first reported a position in FBLG in Q3 2024 and held it in 6 quarters. The position peaked at $161K in Q3 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Cerity Partners reported no remaining FibroBiologics position as of Q1 2026 after selling out during the quarter.
  • Cerity Partners sold 4,696 FibroBiologics shares in Q1 2026, an estimated $21.1K.
  • Cerity Partners first reported a position in FibroBiologics in Q3 2024 and held it in 6 quarters.
  • Cerity Partners's FibroBiologics position peaked at $161K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Cerity Partners's 13F filing for Q1 2026, filed 15 May 2026.